Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W, Wilson JW, Cook ED, Edwards CL, Gibson RV, McElwain DL, Figueroa-Moseley CD, Paskett ED, Roberson NL, Wickerham DL, Wolmark N.

Clin Trials. 2013 Apr;10(2):280-91. doi: 10.1177/1740774512470315. Epub 2013 Jan 18.

PMID:
23335675
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7.

PMID:
22318751
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

Runowicz CD, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Ford LG, Vogel VG, Wolmark N.

Am J Obstet Gynecol. 2011 Dec;205(6):535.e1-5. doi: 10.1016/j.ajog.2011.06.067. Epub 2011 Jun 24.

PMID:
21872200
[PubMed - indexed for MEDLINE]
4.

Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.

Vogel VG, Costantino JP, Wickerham DL, McCaskill-Stevens W, Clarfeld RB, Grant MD, Wolmark N.

J Natl Cancer Inst Monogr. 2010;2010(41):181-6. doi: 10.1093/jncimonographs/lgq041. Review.

PMID:
20956826
[PubMed - indexed for MEDLINE]
5.

Cognitive changes associated with endocrine therapy for breast cancer.

Agrawal K, Onami S, Mortimer JE, Pal SK.

Maturitas. 2010 Nov;67(3):209-14. doi: 10.1016/j.maturitas.2010.07.004. Epub 2010 Aug 4.

PMID:
20688441
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL 3rd, Robidoux A, Margolese RG, James J, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N; National Surgical Adjuvant Breast and Bowel Project.

Cancer Prev Res (Phila). 2010 Jun;3(6):696-706. doi: 10.1158/1940-6207.CAPR-10-0076. Epub 2010 Apr 19.

PMID:
20404000
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The use of tamoxifen and raloxifene for the prevention of breast cancer.

Wickerham DL, Costantino JP, Vogel VG, Cronin WM, Cecchini RS, Ford LG, Wolmark N.

Recent Results Cancer Res. 2009;181:113-9. Review.

PMID:
19213563
[PubMed - indexed for MEDLINE]
8.

Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.

Kondo M, Hoshi SL, Toi M.

Br J Cancer. 2009 Jan 27;100(2):281-90. doi: 10.1038/sj.bjc.6604869. Epub 2009 Jan 13.

PMID:
19142182
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.

Land SR, Ritter MW, Costantino JP, Julian TB, Cronin WM, Haile SR, Wolmark N, Ganz PA.

J Clin Oncol. 2007 Nov 10;25(32):5113-20. Review.

PMID:
17991930
[PubMed - indexed for MEDLINE]
Free Article
10.

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.

Jordan VC.

Eur J Cancer. 2006 Nov;42(17):2909-13. Epub 2006 Oct 24. Review.

PMID:
17064889
[PubMed - indexed for MEDLINE]
11.

An update on breast cancer prevention trials.

Wickerham DL, Fourchotte V.

Int J Gynecol Cancer. 2006;16 Suppl 2:498-501. Review.

PMID:
17010056
[PubMed - indexed for MEDLINE]
12.

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, Pajon ER, Wade JL 3rd, Dakhil S, Lockhart JB Jr, Wolmark N, Ganz PA.

JAMA. 2006 Jun 21;295(23):2742-51. Epub 2006 Jun 5. Erratum in: JAMA. 2007 Sep 5;298(9):973.

PMID:
16754728
[PubMed - indexed for MEDLINE]
13.

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 3rd, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP).

JAMA. 2006 Jun 21;295(23):2727-41. Epub 2006 Jun 5. Erratum in: JAMA. 2007 Sep 5;298(9):973. JAMA. 2006 Dec 27;296(24):2926.

PMID:
16754727
[PubMed - indexed for MEDLINE]
14.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
[PubMed - indexed for MEDLINE]
Free Article
15.

Prevention of hormone-related cancers: breast cancer.

Dunn BK, Wickerham DL, Ford LG.

J Clin Oncol. 2005 Jan 10;23(2):357-67. Review.

PMID:
15637398
[PubMed - indexed for MEDLINE]
Free Article
16.

Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).

Lo SS, Vogel VG.

Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):97-111. Review.

PMID:
14687600
[PubMed - indexed for MEDLINE]
17.

A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials.

Smith RE.

Semin Oncol. 2003 Oct;30(5 Suppl 16):4-13. Review.

PMID:
14613021
[PubMed - indexed for MEDLINE]
18.

Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others.

Smith RE, Good BC.

Endocr Relat Cancer. 2003 Sep;10(3):347-57. Review.

PMID:
14503912
[PubMed - indexed for MEDLINE]
Free Article
19.

Update on breast cancer prevention.

Rastogi P, Vogel VG.

Oncology (Williston Park). 2003 Jun;17(6):799-805; discussion 808-10, 813. Review.

PMID:
12846124
[PubMed - indexed for MEDLINE]
Free Article
20.

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM.

Clin Cancer Res. 2003 Jan;9(1 Pt 2):495S-501S. Review.

PMID:
12538506
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk